GeneTex
United States (US)

Bcl-2 antibody

img12347_18121411_801.jpg

Cat No. GTX27973

Host Rabbit
Clonality Polyclonal
Isotype IgG
Application WB, IHC-Fr, IP, IHC
Reactivity Human, Mouse, Rat
APPLICATION

Application Note

This Bcl-2 antibody is recommended for use in IHC with fresh/frozen sections. It has been tested on paraffin embedded sections but it has not faired well.
For WB:1:200

Calculated MW

26 kDa. ( Note )

Specificity/Sensitivity

Reacts with Bcl-2
PROPERTIES

Form

Liquid

Buffer

PBS with 0.1% sodium azide and 0.2% gelatin

Storage

Store as concentrated solution. Centrifuge briefly prior to opening vial. Store at 4ºC. DO NOT FREEZE.

Concentration

0.2 mg/ml (Please refer to the vial label for the specific concentration.)

Antigen Species

Human

Immunogen

Synthetic peptide (Human) (N terminal).

Purification

IgG fraction

Conjugation

Unconjugated

Note

For laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
TARGET

Synonyms

Bcl2, Apoptosis Regulator,Bcl-2,Ppp1R50,Bcl2

Cellular Localization

Endoplasmic reticulum, outer mitochondrial membrane and nuclear membrane.

Background

Bcl-2 family is a key regulator of apoptosis that function to either inhibit or promote cell death. Over expression of members such as Bcl-2 and Bcl-xL inhibit the apoptotic process (1,2). The Bcl-2 family members are also characterized by dimerizing to further modulate apoptosis. Bag-1, for example, has been found to form a heterodimer with Bcl-2 resulting in the enhancement of the anti-apoptotic effect of Bcl-2 (3,4). Bax and Bak have been shown to play a critical role in cytochrome c release from mitochondria and thus initiate apoptosis (6). Bad plays a critical role in the Bax-mediated apoptosis pathway by dimerizing with Bcl-xL, causing the displacement of Bax. The displacement of Bax allows apoptosis to proceed (7). Bcl-xS, a shorter version of Bcl-xL (lacking amino acids 126-188), apparently utilizes a different pathway than Bax to induce cell death. Some research suggests that Bcl-xS uses a novel mechanism for regulating caspase or it may use an alternate cell death effector pathway (8,9).

Database

Research Area

DATA IMAGES
img12347_18121411_801.jpg

GTX27973 IHC Image